Health · Full coverage

Innovative Lutetium Treatment Completely Eradicates Metastatic Prostate Cancer in Safed Patient

How 3 Israeli newsrooms covered this story — translated into English and compared side by side.

67% center

Center 2Right 1

First reported by Mako · 2 hours ago

What happened

A 66-year-old Israeli man with metastatic prostate cancer achieved complete remission after receiving Lutetium-177 PSMA therapy at Ziv Medical Center in Safed, with doctors calling the response exceptional. The targeted radioactive treatment eliminated all signs of cancer and is now accessible locally to northern residents.

01A 66-year-old man from Kibbutz Degania B fully recovered from metastatic prostate cancer after Lutetium-177 PSMA treatment.
02Imaging and PSA tests post-treatment showed no evidence of disease, indicating complete remission.
03The targeted radioactive therapy delivers radiation directly to prostate cancer cells, minimizing harm to healthy tissue.
04Treatment is available at Ziv Medical Center in Safed without hospitalization and covered by Israel's health basket.
05Advanced Veriton SPECT imaging enabled precise treatment planning and monitoring.
06Ziv Medical Center aims to provide advanced cancer care to northern Israel residents, reducing travel to central regions.

Summary translated & synthesized from the sources below by baba. Read each original for the full report.

In this story

People